Given the growing importance of cancer as one of the most serious challenges facing health systems in Iran and across the world, and as a key concern of all those responsible for safeguarding public health, Isfahan University of Medical Sciences is honored to host the 3rd International Cancer Genomics Congress (CGC2026). This event will bring […]
امروز توفیق اینو داشتیم خدمت استادگرانقدرجناب پروفسور داریوش فرهود، پدر علم ژنتیک ایران برسیم. پروفسور فریدون نوحی رییس محترم انستیتو قلب و عروق شهید رجاییپروفسور مجید ملکی عضو محترم هیات رییسه انستیتوپروفسور سعیده مظلوم زاده معاون محترم پژوهشی انستیتودکتر لیلا عبدالکریمی معاون محترم درمان انستیتو پروفسور آذین علیزاده رییس محترم مرکز تحقیقات کاردیوانکولوژیدکتر مهشید ملکوتیان، […]
برگزاری جلسه هسته مرکزی تیم اجرایی سومین کنگره بین المللی و اولین کنگره استانی کنسرژنومیکس با هدف تشکیل و هماهنگی گروه های کمیته های اجرایی
In the Name of the Wise We are greatly honored to host you—distinguished scientists, researchers, and scholars of biomedical sciences—at the Third International Congress on Cancer Genomics, held in the beautiful and historic city of Isfahan, the cultural and civilizational capital of Islamic Iran. Isfahan is heir to one of the oldest medical schools in […]
Distinguished Colleagues and Global Leaders, Today, I stand before you not only as a Hematology and Oncology subspecialist, but as the voice of thousands of patients whose eyes are fixed on the light of tomorrow. As CEO of the National Cancer Network and on behalf of the Social Responsibility Committee, it is with a deep […]
Dear Colleagues and Friends,It is with great pleasure and excitement that we extend this invitation to you for the 3rdInternational Cancer Genomics Congress (CGC2026). This spring, we are delightedto welcome you to the historic and beautiful city of Isfahan for what promises to be apivotal gathering in our shared mission against cancer.Building on the strong foundations […]
Tehran, Iran | 23–25 October 2024
The workshop focused on the introduction of eukaryotic genome editing technologies, novel approaches to cancer treatment, and gene transfer using CRISPR (CRISPR/Cas9).